Congestive Heart Failure, Atrial Arrhythmia, Atrial Tachyarrhythmia, Atrial Fibrillation

Cardiovascular
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Rhythm Pharmaceuticals
1 program
Cardiac Resynchronization Therapy+Implantable Cardioverter DefibrillatorN/A1 trial
Active Trials
NCT00268320Completed270Est. Jul 2007

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Rhythm PharmaceuticalsCardiac Resynchronization Therapy+Implantable Cardioverter Defibrillator

Clinical Trials (1)

Total enrollment: 270 patients across 1 trials

NCT00268320Rhythm PharmaceuticalsCardiac Resynchronization Therapy+Implantable Cardioverter Defibrillator

Clinical Investigation of the Medtronic Concerto™ Device

Start: Jan 2006Est. completion: Jul 2007270 patients
N/ACompleted

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space